AI Governance for Regulated Industries: Healthcare, Finance & Government

Q: How does AI governance intersect with data privacy law in regulated industries?

The intersection is deep and consequential. Key points include: lawful basis for training on sensitive data (PHI under HIPAA, customer data under GLBA), data minimization in AI training datasets, data subject rights including the right to explanation for automated decisions, and breach notification obligations when AI systems are involved in data incidents.

By Jared Clark, JD, MBA, PMP, CMQ-OE, CPGP, CFSQA, RAC | Certify Consulting

Last updated: 2026-03-17

Artificial intelligence is no longer a future consideration for regulated organizations — it is a present operational reality. From predictive diagnostics in hospital systems to algorithmic lending decisions in banking and automated fraud detection in federal agencies, AI is embedded in workflows that directly affect patient safety, financial fairness, and public trust. Yet the governance infrastructure needed to manage these systems responsibly has lagged dangerously behind the pace of deployment.

According to a 2024 survey by the IBM Institute for Business Value, 77% of executives in regulated industries report that their organizations are deploying AI faster than they can manage the associated risks. That gap — between deployment speed and governance maturity — is precisely where regulatory exposure, reputational harm, and operational failure accumulate.

At Certify Consulting, I've worked with 200+ regulated organizations across healthcare, life sciences, financial services, and government to build AI governance programs that hold up under audit. This pillar article consolidates what I've learned about the unique challenges, regulatory requirements, and practical frameworks that apply to each sector — and where they converge.

What Is AI Governance, and Why Does It Matter More in Regulated Industries?

AI governance is the set of policies, processes, controls, and accountability structures an organization uses to ensure its AI systems are accurate, fair, transparent, secure, and compliant with applicable law. It spans the full AI lifecycle — from initial design and data sourcing through deployment, monitoring, and eventual decommission.

In unregulated industries, inadequate AI governance is a reputational and operational risk. In regulated industries, it is also a legal and compliance risk with direct consequences: enforcement actions, consent decrees, civil money penalties, loss of accreditation, and, in the most serious cases, patient harm or systemic market disruption.

AI governance in regulated industries requires mapping every AI system to the specific regulatory frameworks that govern the domain in which it operates — and that mapping is far more complex than most organizations initially anticipate.

The international standard ISO 42001:2023 — the world's first AI management system standard — provides a sector-agnostic foundation for AI governance. However, sector-specific overlays are essential. Healthcare organizations must reconcile ISO 42001 with FDA 21 CFR Part 11, HIPAA, and increasingly with the FDA's AI/ML-Based Software as a Medical Device (SaMD) action plan. Financial institutions must layer in SR 11-7 model risk management guidance, the Fair Housing Act, ECOA, and emerging state AI laws. Government agencies must account for OMB Memorandum M-24-10, NIST AI RMF (AI 600-1), and FedRAMP authorization requirements for AI-enabled cloud systems.

The Regulatory Landscape: A Cross-Sector Comparison

The table below maps the primary AI governance obligations across the three sectors. Understanding where frameworks overlap — and where they diverge — is the starting point for any serious governance program.

Dimension	Healthcare	Financial Services	Government
Primary AI Standard	ISO 42001:2023 + FDA AI/ML SaMD	ISO 42001:2023 + SR 11-7	NIST AI RMF (AI 600-1) + ISO 42001:2023
Data Privacy Law	HIPAA (45 CFR Parts 160, 164)	GLBA, CCPA/CPRA, state laws	Privacy Act of 1974, FISMA
Bias/Fairness Obligation	OCR guidance, ADA Section 1557	ECOA, Fair Housing Act, CFPB circulars	EO 13985, Civil Rights Laws, OMB M-24-10
Model Risk Management	FDA Software Validation (21 CFR Part 11)	SR 11-7 / OCC 2011-12	NIST RMF (SP 800-37) + AI overlay
Explainability Requirement	Clinical decision support disclosure	Adverse action notices (Reg B)	Algorithmic accountability (OMB M-24-10)
Audit Trail Requirement	21 CFR Part 11 electronic records	SOX, FINRA Rule 4511	FISMA, FedRAMP continuous monitoring
Enforcement Body	FDA, OCR (HHS), CMS	OCC, CFPB, Fed, FDIC, SEC, FINRA	OMB, agency Inspector Generals, GAO
Max Penalty Exposure	$1.9M/year (HIPAA); FDA consent decree	Up to $1M/day (OCC); CFPB civil penalties	Agency debarment; Inspector General referral

This cross-sector view makes one thing immediately clear: the regulatory surface area for AI in regulated industries is not one framework — it is a layered, intersecting matrix of federal statutes, agency guidance, and international standards. Organizations that treat AI governance as a single-standard exercise will find themselves with material compliance gaps.

AI Governance in Healthcare: Patient Safety Is the North Star

The Unique Stakes of Healthcare AI

Healthcare AI operates in an environment where errors have direct clinical consequences. A miscalibrated sepsis prediction model, a biased radiology algorithm, or an AI-driven drug interaction checker with flawed training data can contribute to patient harm. Regulatory bodies know this, and their expectations reflect it.

The FDA's 2021 Action Plan for AI/ML-Based Software as a Medical Device established that AI systems meeting the definition of a medical device — those that diagnose, treat, mitigate, or prevent disease — are subject to premarket review pathways including 510(k) clearance and De Novo authorization. As of 2024, the FDA has authorized more than 950 AI/ML-enabled medical devices, the vast majority in radiology, cardiology, and pathology.

Key Governance Requirements in Healthcare

1. Software Validation Under 21 CFR Part 11 and Part 820 Any AI system used in a regulated manufacturing, laboratory, or clinical decision support context must be validated. Validation is not a one-time event — it is a lifecycle obligation. Under FDA's proposed updates to 21 CFR Part 820 (Quality System Regulation), software validation requirements now explicitly address adaptive AI systems that learn post-deployment. This means your governance program must include predefined change control protocols for model updates.

2. HIPAA and AI Training Data Training healthcare AI on protected health information (PHI) without a proper legal basis is a HIPAA violation. Organizations must establish whether AI training constitutes "treatment, payment, or healthcare operations" under 45 CFR §164.506, whether a Business Associate Agreement (BAA) is required with the AI vendor, and whether de-identification under §164.514 was properly executed. The Office for Civil Rights (OCR) has increasingly scrutinized AI vendor relationships in HIPAA enforcement.

3. Algorithmic Bias and Section 1557 The ACA's Section 1557 nondiscrimination provisions, as clarified in the 2024 final rule (89 FR 37522), explicitly prohibit the use of clinical algorithms that discriminate on the basis of race, color, national origin, sex, age, or disability in federally funded health programs. This is a landmark regulatory development: healthcare organizations are now directly accountable for the disparate impact of AI clinical decision support tools, even when those tools are sourced from third-party vendors.

4. Clinical Decision Support (CDS) Classification Under the 21st Century Cures Act and FDA's 2022 CDS guidance, not all AI-powered CDS is regulated as a medical device. The four-factor test (purpose, display of basis, ability for independent review, and whether a healthcare professional is the intended user) determines regulatory status. This classification decision has major downstream governance implications — it determines validation depth, documentation requirements, and audit trail obligations.

Practical Recommendation for Healthcare Organizations

Healthcare AI governance programs should be structured around three pillars: validation rigor (lifecycle-based, documented per FDA expectations), vendor due diligence (contractual AI transparency obligations and BAA coverage), and bias monitoring (ongoing statistical surveillance of model outputs stratified by protected class). ISO 42001:2023 clause 6.1.2 (AI risk assessment) and Annex A control A.6.2 (AI system impact assessment) provide the management system scaffolding for all three.

AI Governance in Financial Services: Model Risk Meets Algorithmic Accountability

The Model Risk Management Foundation

Financial services has the most mature AI governance tradition of any regulated sector, rooted in the Federal Reserve's and OCC's SR 11-7 guidance on model risk management, published in 2011 and still the authoritative framework for U.S. banking regulators. SR 11-7 defines a model as "a quantitative method, system, or approach that applies statistical, economic, financial, or mathematical theories, techniques, and assumptions to process input data into quantitative estimates." Under this definition, virtually every AI system used in credit, fraud, trading, or compliance qualifies as a model subject to SR 11-7 governance.

A 2023 Federal Reserve survey found that large U.S. bank holding companies maintain an average of 750 models per institution, with AI/ML models representing the fastest-growing segment of model inventories. This scale makes governance infrastructure — model inventories, tiered risk classification, independent validation functions, and board-level model risk appetite statements — non-negotiable.

Fair Lending and Algorithmic Discrimination

The intersection of AI and fair lending law is one of the most active areas of regulatory scrutiny in financial services. Under the Equal Credit Opportunity Act (ECOA) and its implementing Regulation B (12 CFR Part 1002), creditors must provide adverse action notices with specific reasons when denying credit. The CFPB has made clear in its 2022 circular on adverse action and AI that "the fact that a credit decision was made by an algorithm does not relieve a creditor of its obligation to provide specific reasons" — and that "we cannot determine why" is not an acceptable adverse action reason.

The CFPB, OCC, Federal Reserve, FDIC, and NCUA issued a joint statement on AI in financial services in 2023, signaling that regulators will examine AI governance as part of routine safety and soundness examinations. Organizations that cannot demonstrate model documentation, independent validation, and ongoing performance monitoring for AI models will face examination findings.

Key Governance Requirements in Financial Services

1. Model Inventory and Tiered Risk Classification Every AI system meeting the SR 11-7 model definition must be inventoried, assigned a risk tier (high/medium/low), and reviewed on a schedule commensurate with its risk. High-risk models — those used in credit underwriting, stress testing, or AML/BSA — require independent validation by a function separate from model development.

2. Explainability for Adverse Action Compliance Institutions using black-box models (e.g., deep learning, gradient boosting ensembles) for credit decisions must implement explainability techniques — SHAP values, LIME, or counterfactual explanations — sufficient to generate specific, individualized adverse action reasons. This is not optional; it is a regulatory requirement under Reg B and the FCRA.

3. Third-Party AI Risk Management The OCC's 2023 interagency guidance on third-party relationships explicitly extends model risk management obligations to AI systems provided by fintechs, cloud vendors, and data aggregators. Banks cannot outsource their SR 11-7 obligations to vendors. Contractual provisions must include model documentation access, validation rights, and performance reporting.

4. CRA and Fair Lending Examinations Community Reinvestment Act examiners are increasingly reviewing AI-driven marketing and outreach systems to assess whether they have a disparate impact on low-to-moderate income geographies or protected class members. This extends AI governance obligations beyond credit decisioning into marketing, servicing, and collections.

Practical Recommendation for Financial Services Organizations

Build your AI governance program on SR 11-7 as the operational backbone, overlay ISO 42001:2023 for management system structure, and conduct an annual fair lending AI model review that specifically stress-tests for disparate impact. The governance gap I most frequently find at financial institutions is the absence of a formal AI use case intake process — models are deployed without ever entering the inventory. Solving intake governance solves the majority of downstream compliance exposure.

AI Governance in Government: Public Trust and Algorithmic Accountability

The Unique Obligations of Government AI

Government agencies deploying AI systems operate under a distinct accountability framework: they are not just managing organizational risk — they are managing the exercise of sovereign power over individuals' lives, liberty, and property. An AI system that inaccurately flags a benefits applicant for fraud, miscalculates a tax liability, or generates a biased risk score in a criminal justice context is not merely a compliance failure — it is a due process concern with constitutional dimensions.

OMB Memorandum M-24-10, issued in March 2024, is the most significant federal AI governance directive to date. It requires agencies to: designate a Chief AI Officer (CAIO) by a defined deadline; maintain an annual inventory of AI use cases; conduct impact assessments for rights-impacting and safety-impacting AI; and implement minimum practices for high-impact AI. Agencies were required to complete their first AI use case inventories by the end of FY2024.

NIST AI Risk Management Framework (AI RMF 1.0 and AI 600-1)

The NIST AI RMF, published in January 2023, is the foundational voluntary framework for U.S. federal AI governance. Its four core functions — GOVERN, MAP, MEASURE, MANAGE — provide a lifecycle-based approach to AI risk. NIST AI 600-1, the companion profile for generative AI, addresses the additional risks posed by large language models and foundation models, including hallucination, data provenance, and dual-use concerns.

For federal agencies, AI RMF alignment is increasingly quasi-mandatory: OMB M-24-10 references the RMF directly, and agency AI governance programs that cannot map to its functions will face scrutiny in IG audits and GAO reviews.

Key Governance Requirements for Government Agencies

1. Rights-Impacting and Safety-Impacting AI Classification OMB M-24-10 creates two high-stakes categories: "rights-impacting AI" (systems that affect civil rights, civil liberties, or equal opportunities) and "safety-impacting AI" (systems that affect health, safety, or critical infrastructure). Both categories require enhanced governance — human oversight mechanisms, impact assessments, public disclosure, and ongoing monitoring. Agencies must complete these assessments for in-scope systems or cease use.

2. AI Use Case Inventories Section 5 of OMB M-24-10 mandates annual public disclosure of agency AI use case inventories, with limited exemptions for national security systems. This transparency requirement is unprecedented and creates a direct accountability mechanism: civil society organizations, Congressional oversight bodies, and the public can review what AI systems agencies are using and evaluate the governance documentation.

3. FedRAMP and AI-Enabled Cloud Systems AI systems delivered via cloud services are subject to FedRAMP authorization requirements. The FedRAMP Program Management Office issued updated guidance in 2024 for AI-enabled cloud services, requiring cloud service providers to document AI components in their System Security Plans (SSPs) and address AI-specific risks in their continuous monitoring programs.

4. Algorithmic Impact Assessments Multiple agencies — including the Social Security Administration, Department of Labor, and DHS — have implemented or are implementing algorithmic impact assessment processes consistent with EO 13985 (advancing racial equity) and EO 14110 (safe, secure, and trustworthy AI). These assessments must evaluate disparate impact on protected classes, document mitigation measures, and be reviewed by civil rights officers.

Practical Recommendation for Government Agencies

The most urgent governance gap I see in government is the disconnection between IT procurement and AI governance. Agencies are acquiring AI capabilities through existing IT contract vehicles without triggering AI-specific review processes. Establishing a formal AI acquisition review gate — integrated into the FAR procurement process — is the single highest-leverage governance investment a federal agency can make right now.

Where the Sectors Converge: A Common AI Governance Architecture

Despite their regulatory differences, healthcare, financial services, and government organizations share a common AI governance architecture. Building this architecture once — using ISO 42001:2023 as the management system spine — and then adapting it with sector-specific controls is far more efficient than building sector-specific programs from scratch.

The five universal pillars of AI governance in regulated industries are:

1. AI Inventory and Classification Every deployed AI system must be documented, classified by risk level, and assigned an accountable owner. Without a complete inventory, governance is structurally impossible.

2. Pre-Deployment Risk Assessment Risk assessment before deployment — evaluating accuracy, bias, explainability, security, and regulatory compliance — must be documented and reviewable. ISO 42001:2023 clause 6.1.2 provides the management system requirement; sector-specific frameworks define the content depth.

3. Ongoing Performance Monitoring AI models drift. Training data distributions shift. The regulatory and clinical environment changes. Continuous monitoring — with defined thresholds for re-validation or decommission — is non-negotiable in regulated environments.

4. Vendor and Third-Party AI Governance The majority of AI systems in regulated organizations are sourced from third parties. Contractual AI governance obligations — documentation access, audit rights, incident notification, bias testing results — must be embedded in vendor agreements.

5. Human Oversight and Override Mechanisms All three sectors increasingly require demonstrated human oversight for high-stakes AI decisions. This is not just a documentation exercise — organizations must demonstrate that oversight mechanisms are operationally effective, not theoretical.

Frequently Asked Questions About AI Governance in Regulated Industries

What is the difference between AI governance and AI compliance?

AI compliance means meeting the minimum regulatory requirements applicable to your AI systems — avoiding violations, passing audits, and responding to regulatory inquiries. AI governance is broader: it is the proactive management system that ensures AI systems are designed, deployed, and monitored in alignment with your organization's risk appetite, ethical commitments, and regulatory obligations. Compliance is an output of strong governance, not a substitute for it.

Do all AI systems in regulated industries need to be governed the same way?

No. Risk-tiered governance is the right approach. A low-risk AI system automating internal scheduling does not warrant the same validation rigor, documentation depth, or oversight intensity as a high-risk AI system making clinical diagnoses or credit underwriting decisions. The key is having a documented, defensible methodology for risk classification that regulators can review — and applying governance controls proportionate to that classification.

Is ISO 42001:2023 certification required for regulated industries?

ISO 42001:2023 certification is not currently mandated by any U.S. federal regulator, but it is increasingly referenced as a recognized governance standard. More importantly, the management system discipline it requires — documented policies, risk assessment processes, defined roles and responsibilities, internal audit, and management review — directly addresses the governance gaps that regulators are finding in examinations. Organizations certified to ISO 42001:2023 are demonstrably better positioned for regulatory scrutiny than those without a formal AI management system.

How does AI governance intersect with data privacy law in regulated industries?

The intersection is deep and consequential. AI systems in regulated industries are trained on, and make decisions about, data that is simultaneously subject to privacy law (HIPAA, GLBA, Privacy Act) and AI governance requirements. Key intersection points include: lawful basis for training on sensitive data, data minimization in AI training datasets, data subject rights (including the right to explanation for automated decisions), and breach notification obligations when AI systems are involved in data incidents.

What should organizations do first when building an AI governance program?

Start with an AI inventory — a complete, accurate census of every AI system your organization currently uses or plans to deploy, including third-party AI embedded in enterprise software. Without knowing what AI you have, you cannot assess its risk, assign accountability, or determine applicable regulatory requirements. In my experience working with 200+ regulated organizations, the inventory step routinely surfaces 30–50% more AI systems than leadership believed existed.

Getting Started: Building Your AI Governance Program

If your organization is in healthcare, financial services, or government and is deploying AI without a formal governance program, you are accumulating regulatory exposure with every passing quarter. The regulatory landscape is not getting simpler — the FDA, CFPB, OCC, and OMB are all intensifying their AI oversight activities, and the gap between leading-practice governance and minimum compliance requirements is widening.

At Certify Consulting, we help regulated organizations build AI governance programs that are audit-ready, operationally practical, and structured to scale as your AI portfolio grows. With a 100% first-time audit pass rate across 200+ client engagements and 8+ years of specialized experience in regulated industries, we have the depth to help you move from governance gap to governance confidence.

Explore our resources: - AI Governance Program Assessment — understand your current maturity and priority gaps - ISO 42001:2023 Implementation Guide for Regulated Industries — the management system foundation every regulated AI program needs

Last updated: 2026-03-17

Jared Clark is the principal consultant at Certify Consulting and holds credentials including JD, MBA, PMP, CMQ-OE, CPGP, CFSQA, and RAC. He advises regulated organizations across healthcare, life sciences, financial services, and government on AI governance, quality management systems, and regulatory strategy.